Full text is available at the source.
Lympho-myeloid aggregate-infiltrating CD20+ B cells display a double-negative phenotype and correlate with poor prognosis in esophageal squamous cell carcinoma
Special B cells with unusual features in immune cell clusters link to worse outcomes in esophageal cancer
AI simplified
Abstract
In a study of 147 esophageal squamous cell carcinoma samples, lympho-myeloid aggregates were associated with poor prognosis.
- Tumor-infiltrating B cells can be categorized into lympho-myeloid aggregates (LMAs) and tertiary lymphoid structures (TLSs).
- LMAs were found to be widely distributed and their presence, particularly in the intra-tumor subregion, correlated with worse survival outcomes.
- In contrast, TLSs exhibited a positive clinical significance for patients.
- A four-level immune type based on the counts of LMAs and TLSs was identified as an independent predictor of survival.
- The predominant B cell phenotype in LMAs was identified as double-negative B cells, which were associated with reduced overall survival.
- Double-negative B cells showed a close relationship with regulatory T cells and expressed genes related to antigen processing and presentation.
AI simplified